Meeting
2018 ASCO Annual Meeting
Outcomes of oxaliplatin-based (Ox) chemotherapy (CT) on R0 resection of colonic liver metastases (CLM).
Authors
Nicholas Adam Bosma
Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
Nicholas Adam Bosma , Maclean Thiesen , Winson Y. Cheung , Daniel John Renouf , Caroline Speers , Derek Tilley , Elijah Dixon , Chad Ball , Patricia A. Tang , Richard M. Lee-Ying
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3538)
DOI
10.1200/JCO.2018.36.15_suppl.3538
Abstract #
3538
Poster Bd #
31
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Effectiveness of biologic agents among Hispanics in the US with metastatic colorectal cancer.
First Author: Riya Jayesh Patel
Poster
2021 ASCO Annual Meeting
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases: The PARLIM trial (AIO KRK 0314).
First Author: Dominik Paul Modest
Poster
2015 Gastrointestinal Cancers Symposium
Impact of FOLFOXIRI regimen on early “Conversion” and long-term outcome in patients with initially unresectable colorectal liver metastases.
First Author: Mitsuo Shimada
Poster
2014 Gastrointestinal Cancers Symposium
Cost differential among systemic therapies for colon cancer.
First Author: Hasan Nadeem